BRAF/MEK inhibitors use to treat ventriculoperitoneal shunt‐associated ascites in pediatric low‐grade gliomas

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Pediatric blood & cancer 2024-08, Vol.71 (8), p.e31058-n/a
Hauptverfasser:	Amayiri, Nisreen, Obeidat, Mouness, Laban, Dima Abu, Musharbash, Awni, Al‐Hussaini, Maysa, Maraqa, Bayan, Ibrahimi, AhmadKh, Sarhan, Nasim, Bouffet, Eric
Format:	Artikel
Sprache:	eng
Schlagworte:	Adolescent Ascites Ascites - drug therapy Ascites - etiology Ascites - pathology Brain Neoplasms - drug therapy Brain Neoplasms - pathology Child Child, Preschool Female Glioma Glioma - drug therapy Glioma - pathology Humans Male MEK inhibitors Pediatrics Protein Kinase Inhibitors - adverse effects Protein Kinase Inhibitors - therapeutic use Proto-Oncogene Proteins B-raf - antagonists & inhibitors Proto-Oncogene Proteins B-raf - genetics Pyridones Pyrimidinones Ventriculoperitoneal Shunt
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!